Lexaria Bioscience Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $2.8M
Liabilities Breakdown FY2020
Total Liabilities: $346.0K
Asset Breakdown
Total Assets: $2.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.3M | 45.7% |
| Accounts Receivable | $313.9K | 11.1% |
| Inventory | $116.9K | 4.1% |
| Property, Plant & Equipment | $483.4K | 17.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $292.0K | 10.3% |
| Other Assets | $328.3K | 11.6% |
Liabilities Breakdown
Total Liabilities: $346.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $346.0K | 100.0% |